Fundz

Aurora Bio, Inc. reported raising $175,000 in an initial SEC Form D filing

PRIVATEDec 27, 2019

Amount Raised

$175,000

$175,000 sold, per SEC Form D (first sale Dec 27, 2019)

Round Type

Pre-Seed

San FranciscoBiotechnology

Quick answer

Aurora Bio, Inc. raised $175,000 in a Pre-Seed round, dated December 27, 2019. Aurora Bio, Inc. is based in San Francisco, California, United States.

How much did Aurora Bio, Inc. raise?
Aurora Bio, Inc. raised $175,000 in a Pre-Seed round on December 27, 2019.
What does Aurora Bio, Inc. do?
Aurora Bio at aurorabioinc.com is a clinical-stage biotechnology company focused on systemic amyloidosis, including AL, ATTR, ALECT2 and other forms.
Where is Aurora Bio, Inc. based and how big is it?
Aurora Bio, Inc. is based in San Francisco, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Aurora Bio, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • mBio Diagnostics, Inc. raised $550K (Seed) on February 10, 2020.
  • AcuityBio Corp raised $175K (Seed) on February 10, 2020.
  • Tolerion, Inc. raised $23M on February 10, 2020.
  • Torus Biosystems, Inc. raised $1.5M (Seed) on February 7, 2020.
  • Outset Medical raised $115M on February 7, 2020.
  • TamuroBio Inc. raised $4M (Seed) on February 7, 2020.

Who to call at Aurora Bio, Inc., and when

A new round usually means Aurora Bio, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aurora Bio, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aurora Bio, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aurora Bio, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aurora Bio, Inc.

Location

208 SECOND AVENUE

San Francisco, California, United States

About

Aurora Bio at aurorabioinc.com is a clinical-stage biotechnology company focused on systemic amyloidosis, including AL, ATTR, ALECT2 and other forms. Aurora Bio is a biotechnology company utilizing patented therapeutic imaging to cure amyloidosis and amyloid fibrils in the human body

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aurora Bio, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Aurora Bio, Inc.'s next move

See what Strategic adds

Aurora Bio, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.